Archive for October, 2008
« Previous EntriesStudy Reveals Rising Suicide Rate Among Older South Asian Women - Royal College Of Psychiatrists
Friday, October 31st, 2008The suicide rate in older women of South Asian origin is increasing, according to new research published in the November issue of the British Journal of Psychiatry. Suicide rates among those over the age of 65 are now double that of other women living in England and Wales. The psychiatrists […]
High Blood Pressure Is Related To Depression In Elderly Subjects
Friday, October 31st, 2008An epidemiological study performed in Spain discloses a relationship between high blood pressure and depression in the elderly in the current issue of Psychotherapy and Psychosomatics. A positive association between hypertension and depression has been reported in some inquiries but not in others, and the relationship was limited to individuals with diastolic […]
Program To Engage School Leaders In Teen Suicide Prevention, Wyoming Department Of Health
Thursday, October 30th, 2008With suicide the second-leading cause of death for Wyoming youths ages 15-19, the Wyoming Department of Health is beginning a new program with public and private partners to help address the role of schools in youth suicide prevention.
Maine Receives 500,000 Dolars Grant To Support Youth Suicide Prevention Efforts
Thursday, October 30th, 2008The Maine Youth Suicide Prevention Program (MYSPP) recently learned that it has been selected to receive a $500,000 grant to enhance its efforts in high schools across the state. The U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) awarded 18 grants totaling almost $27 million over three years. Awards ranged form $317,000 […]
High Blood Pressure Is Related To Depression In Elderly Subjects
Thursday, October 30th, 2008An epidemiological study performed in Spain discloses a relationship between high blood pressure and depression in the elderly in the current issue of Psychotherapy and Psychosomatics. A positive association between hypertension and depression has been reported in some inquiries but not in others, and the relationship was limited to individuals with diastolic […]
Two Per Cent Of People In England In Contact With NHS Specialist Mental Health Services, New Report Shows
Wednesday, October 29th, 2008One in 50 people in England were in contact with NHS specialist services for those with severe or enduring mental health problems in 2006-07, according to a new report by The NHS Information Centre. The number accessing specialist services, which cover care by specialist psychiatric teams in hospital or in the […]
WPIC Partners With Pitt And Community Members To Bring Unique Depression Counseling To Students
Wednesday, October 29th, 2008According to national statistics, one out of four college students will experience some form of depression by the age of 24, and nearly half of all college students report feeling so depressed at some point in time that they have trouble functioning.
Studies Look At Medicaid Proof-of-Citizenship Requirements, Depression Treatment Among Black Coronary Heart Disease Patients
Tuesday, October 28th, 2008“Ethnic Differences in the Treatment of Depression in Patients With Ischemic Heart Disease,” American Heart Journal: The study examines the differences in depressive symptoms and antidepressant treatment among blacks and whites undergoing a coronary angiography to diagnose heart disease.
Attempted Suicide 4 Times More Likely In Youth From Poor Neighborhoods
Tuesday, October 28th, 2008Youth in their late teens who live in poor neighbourhoods are four times more likely to attempt suicide than peers who live in more affluent neighbourhoods, according to a new study from Canada’s Université de Montréal and Sainte-Justine Hospital Research Center, as well as Tufts University in the U.S. The researchers also found youth from […]
Auspex Pharmaceuticals Announces Positive Results From Clinical Study Of SD-254, A Next-Generation Potential Treatment For Depression
Tuesday, October 28th, 2008Auspex Pharmaceuticals, a developer of next-generation medicines with improved safety and performance through the targeted deuteration of clinically validated drugs, today announced positive results from its Phase 1 clinical trial evaluating SD-254, a Selective Serotinin-Norepinephrine Reuptake Inhibitor (SNRI). Auspex is developing SD-254, a deuterium-substituted version of venlafaxine, for the treatment of Major Depressive Disorder.
« Previous Entries